Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

ComputerTalk for the Pharmacist November/December 2019

PHSI President Tim Kosty and Vice President Don Dietz contributed to the November/December 2019 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Tim and Don discuss how the oversupply of pharmacists along with evolving technology may lead to new offerings of innovative clinical services. Click here to read Tim and Don’s article entitled Read More →

Tim Kosty to Present at ASAP 2020 Annual Conference

PHSI President Tim Kosty will be presenting at the American Society for Automation in Pharmacy (ASAP) 2020 Annual Conference on January 15-17 in Amelia Island, Florida. Tim will be discussing the California Consumer Privacy Act (CCPA), including requirements that covered businesses must comply with, system changes required, and potential unintended consequences for businesses and consumers. Read More →

Last Call for USP Chapter <800>

On December 1, 2019, changes will go into effect that impact pharmacies, pharmaceutical manufacturers, and wholesalers. The United States Pharmacopeia (USP) introduced its new chapter <800> on handling hazardous drugs. Regulatory agencies worldwide will begin enforcement on December 1, 2019. The USP initially announced a June 1, 2019 rollout for chapter <800>, but a six-month Read More →

Latest from the Blog

Unapproved Products and the Drug Pricing Compendia

Most medical foods, nutritional supplements, dietary supplements, probiotics, and multivitamins are considered unapproved products according to the Food and Drug Administration (FDA).  The FDA defines dietary supplements as “products taken by mouth that contain a ‘dietary ingredient’. Dietary ingredients include vitamins, minerals, amino acids, and herbs or botanicals, as well as other substances that can Read More →

PHSI’s David Schuetz Named NCPDP Work Group 2 Product Review & Billing Unit Exception Task Group Co-Lead

PHSI’s Senior Consultant David Schuetz will be an NCPDP WG 2 Product Review & Billing Unit Exception Task Group Co-Lead. Work Group 2 Product Identification This work group deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units, Read More →

Payer/PBM Owned Specialty Pharmacies…The Next Frontier for 340B

340B eligible hospitals and health systems have realized that many of their patients are not allowed access to their specialty pharmacies, due to plan sponsors (employers/health plans/PBMs) having an exclusive arrangement with the plan sponsors’ specialty pharmacies. To resolve this issue, 340B covered entities are now partnering with the big PBM/payer-owned specialty pharmacies; in exchange, Read More →